TD Cowen raised the firm’s price target on Thermo Fisher (TMO) to $696 from $654 and keeps a Buy rating on the shares. The firm adjusted targets in the life science tools space as part of a Q4 outlook. While the bar is higher for the Q4 results following the recent share rallies, many companies “already soft guided” 2026, the analyst tells investors in a research note. TD believes this sets room for upside in 2026.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $650 from $610 at Evercore ISI
- Thermo Fisher price target raised to $700 from $650 at BofA
- Thermo Fisher price target raised to $675 from $635 at Wells Fargo
- PayPal downgraded, Roku upgraded: Wall Street’s top analyst calls
- Thermo Fisher upgraded to Buy from Neutral at Citi